Robert Calandra is an independent journalist in the Philadelphia area who writes about healthcare and other issues. Aine Cryts contributed reporting.
Association Found Between MAFLD and Patients With Chronic HBV-related HCC
A retrospective study found that chronic hepatitis B-related hepatocellular carcinoma (HCC) patients with metabolic-associated fatty liver disease (MAFLD) had better outcomes than patients who did not have MAFLD.
Physicians Highlight Urgent Global Efforts Needed to Achieve WHO's Hepatitis C Elimination Goals by 2030
Since the introduction of direct-acting antiviral therapies, which boast a 95% cure rate, the reported number of HCV cases has fallen.
Only 1 in 3 Cured of Hepatitis C, Despite the Efficacy Antivirals, Says CDC Report
That is the rate among those with health insurance. It is 1 in 6 among those without it. Prices have dropped but cost remains a barrier and there are other ones.
Hep B Infection and Assisted Reproductive Technology: Are the Outcomes the Same?
The answer is no. Research findings reported in JAMA Network Open show no association between hepatitis B status and poor birth outcomes among those who get pregnant with freeze-thaw embryo transfer whereas among natural births, hepatitis B infection in mothers is linked to miscarriage and preterm birth.
Is Telehealth Leaving Some Patients Behind?
Researchers who analyzed telehealth for patients at federally qualified health centers document problems with everything from broadband access to digital literacy to poor translations.
Yale Researchers Explore Liver-Brain Connection
Their study found an association between liver fibrosis and cognitive performance. Some research has suggested that neurotoxic metabolites produced in an injured liver may cross the blood-brain barrier.
In Texas, Low Hepatitis B Vaccination Rates Among People Living with HIV
Researchers found that only 9% of vaccine-eligible patients at HIV Centers in Dallas, Houston and San Antonio had completed the three-dose series in a 365-day time period.
New Research Tool for Hepatitis B Developed by Rockefeller University Scientists
Charles Rice’s work led to the development of antiviral cures of hepatitis C. Now his lab is turning to hepatitis B and a technique that uses pregenomic RNA.
Positive Real-World Results for Hepatitis D Treatment, Bulevirtide
The antiviral has not been approved by FDA. Gilead Sciences received a complete response letter late last year.
Men Are Reluctant Patients
Dated notions and lack of an early connection to healthcare keep men from seeking care.
Biden’s Hepatitis C Proposal: Not Modest and Far From Certain
The administration unveiled the $11 billion plan in March. Now the hard part: Getting Congress to fund it.
For Racial Disparities in Chronic Hepatitis B Treatment, Look at the Treatment Criteria
Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
Study Shows Interferon-based Treatment of Hep C in Japan Reduced Hepatocellular Carcinoma Occurence
Researchers suggest future studies should compare interferon-based versus noninterferon-based treatment and the effects on hepatocellular carcinoma.
The Lonely Have Plenty of Company
Social isolation loneliness is increasing and not just because of the COVID-19 pandemic. Research shows it can have devastating health consequences.
Prevalence of Hep C Higher Among TGD Individuals
Other research has come to a similar conclusion, but this study used an insurance claims database to make a more rigorous comparison between transgender and gender-diverse (TGD) people and cisgender individuals.
In the Viral Hepatitis Alphabet Soup, the Least Known and Investigated is E
The hepatitis A, B and C viruses are common in the U.S. , and hepatitis D is a fellow traveler with B. But the hepatitis E virus infects millions of people in the world each year, and the infection can be a serious illness. German researchers reported findings earlier this year that may pave the way for improved treatment of hepatitis E infections.
Look to Prison-Based Programs to Stop HCV Transmission
A modeling study involving people who are incarcerated and those that inject drugs in Australia shows that incarceration is a risk factor for transmission of the hepatitis C virus (HCV). The results highlight the importance of HCV programs targeting prison populations.
Delaying ERCP for Acute Bilary Pancreatis May Be OK
Thai researchers found that delaying endoscopic retrograde cholangiopancreatograpy was not associated with disease-related or ERCP-related complications.
COVID-19 Poses Special Risk for People With Chronic Liver Disease
Austrian study found that approximately one-quarter of patients with chronic liver disease and COVID-19 developed laboratory signs of cholestatic liver failure.
As Liver Transplant Patients Live Longer, Kidney Disease Has Become a Risk
A review of 23 studies found that evidence of kidney disease before a liver transplant is the strongest predictor of kidney disease afterward.
Robotic Surgery for HCC is Safe and Effective, Study Finds
A retrospective study published in JAMA Surgery shows that robotic liver resection for hepatocellular carcinoma is associated with shorter hospital stays and fewer admissions to the intensive care unit than open surgery, despite longer operating time and greater blood loss.
Previously Incarcerated Vets Not Shortchanged When It Comes to Hepatitis C Care, Study Finds
Results suggest that Veterans Health Administration’s outreach efforts to veterans with hepatitis C who had been previously incarcerated could serve as a model.
CMS Grades 21 Payment Models
The nine models geared toward acute and specialty care produced better results than the 12 that focused on primary care and population health.
Can the COVID-19 Vaccine Help Hepatitis B Patients?
In the three cases documented by researchers, hepatitis B surface antigen (HBsAG) levels were reduced by more than 50% after Japan began its COVID-19 vaccination program.
There Is No Cure for Chronic Hepatitis B. That Could Change.
A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.
Algorithm Helps Identify Best Treatment for Recurrent Hepatocellular Carcinoma
Using survival after recurrence as the measure, most patients would benefit from reoperative hepatectomy or thermoablation, according to an algorithm developed by Italian researchers. The researchers stress that the algorithm would be used to guide decisions by physicians and patients, not replace them.
Some experts want to see more funding for hospice care in the home. Others say the advantages of hospice in a hospital or nursing home have been underrated.
ACO Update: The Pathways to Success Program
The program implemented by the Trump administration is designed to put more Medicare Shared Savings Program ACOs into two-sided risk. An industry group has discouraged participation in the program.
A Dangerous Pairing: COVID-19 & Obesity - Heightened Risk for COVID-19 Severity
No Giving It Short Shrift: COVID-19 Can Be a Long Haul
“Long COVID” is more likely to affect older people and those who have been hospitalized, but younger people with milder symptoms are not immune to lingering symptoms. One plausible explanation is that the infection results in the activation of autoantibodies.
2 Clarke Drive Cranbury, NJ 08512